- Home
- WASH vs IMAB Comparison
WASH vs IMAB Comparison
Compare WASH & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- IMAB
- Stock Information
- Founded
- WASH 1800
- IMAB 2014
- Country
- WASH United States
- IMAB United States
- Employees
- WASH N/A
- IMAB N/A
- Industry
- WASH Major Banks
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- IMAB Health Care
- Exchange
- WASH Nasdaq
- IMAB Nasdaq
- Market Cap
- WASH 524.8M
- IMAB 486.4M
- IPO Year
- WASH N/A
- IMAB 2020
- Fundamental
- Price
- WASH $27.43
- IMAB $4.63
- Analyst Decision
- WASH Hold
- IMAB Strong Buy
- Analyst Count
- WASH 4
- IMAB 6
- Target Price
- WASH $30.25
- IMAB $7.50
- AVG Volume (30 Days)
- WASH 185.5K
- IMAB 2.2M
- Earning Date
- WASH 10-20-2025
- IMAB 11-14-2025
- Dividend Yield
- WASH 8.18%
- IMAB N/A
- EPS Growth
- WASH N/A
- IMAB N/A
- EPS
- WASH N/A
- IMAB N/A
- Revenue
- WASH $115,241,000.00
- IMAB N/A
- Revenue This Year
- WASH $57.40
- IMAB N/A
- Revenue Next Year
- WASH $9.62
- IMAB N/A
- P/E Ratio
- WASH N/A
- IMAB N/A
- Revenue Growth
- WASH N/A
- IMAB N/A
- 52 Week Low
- WASH $24.95
- IMAB $0.60
- 52 Week High
- WASH $40.59
- IMAB $6.79
- Technical
- Relative Strength Index (RSI)
- WASH 46.13
- IMAB 48.75
- Support Level
- WASH $27.19
- IMAB $4.13
- Resistance Level
- WASH $28.18
- IMAB $4.88
- Average True Range (ATR)
- WASH 0.70
- IMAB 0.67
- MACD
- WASH 0.13
- IMAB -0.14
- Stochastic Oscillator
- WASH 72.01
- IMAB 18.80
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).